Clinical Trial Update: Servo-n HFOV Study: Safety and Performance in Neonates and Infants

View source ↗

Summary

Clinical trial update indicates the Servo-n HFOV study in neonates and infants is currently active but not recruiting, evaluating safety and performance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Respiratory Failure
• Neonatal Respiratory Failure

Drugs mentioned

• Servo-n HFOV

Snippet

Sponsor: Maquet Critical Care AB | Conditions: Elective HFOV for Respiratory Failure in Neonates/Infants, Rescue HFOV in Neonates and/Infants With Refractory Respiratory Failure Under Conventional Therapy | Status: ACTIVE_NOT_RECRUITING